Eli Lilly & Co. (LLY)
1427.28
-10.01
(-0.70%)
USD |
NYSE |
Nov 12, 16:00
1443.00
+15.72
(+1.10%)
Pre-Market: 04:46
Eli Lilly Free Cash Flow (Quarterly) : 4.157B for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.157B |
| June 30, 2026 | 4.475B |
| March 31, 2026 | 2.803B |
| December 31, 2025 | 254.20M |
| September 30, 2025 | 6.028B |
| June 30, 2025 | 1.283B |
| March 31, 2025 | -1.601B |
| December 31, 2024 | 726.60M |
| September 30, 2024 | -458.90M |
| June 30, 2024 | 63.40M |
| March 31, 2024 | 83.20M |
| December 31, 2023 | -1.963B |
| September 30, 2023 | -1.812B |
| June 30, 2023 | -204.40M |
| March 31, 2023 | 827.10M |
| December 31, 2022 | 1.024B |
| September 30, 2022 | 1.565B |
| June 30, 2022 | 369.70M |
| March 31, 2022 | 1.642B |
| December 31, 2021 | 1.762B |
| September 30, 2021 | 1.176B |
| June 30, 2021 | 1.244B |
| March 31, 2021 | 1.205B |
| December 31, 2020 | 995.70M |
| September 30, 2020 | 1.392B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.972B |
| March 31, 2020 | 111.10M |
| December 31, 2019 | 1.637B |
| September 30, 2019 | 1.169B |
| June 30, 2019 | 766.20M |
| March 31, 2019 | -89.30M |
| December 31, 2018 | 825.00M |
| September 30, 2018 | 1.822B |
| June 30, 2018 | -340.70M |
| March 31, 2018 | 200.00M |
| December 31, 2017 | 1.25B |
| September 30, 2017 | 1.433B |
| June 30, 2017 | 1.430B |
| March 31, 2017 | -660.90M |
| December 31, 2016 | 1.652B |
| September 30, 2016 | 1.432B |
| June 30, 2016 | 1.156B |
| March 31, 2016 | -481.20M |
| December 31, 2015 | 250.10M |
| September 30, 2015 | 781.20M |
| June 30, 2015 | 588.70M |
| March 31, 2015 | -473.40M |
| December 31, 2014 | 890.70M |
| September 30, 2014 | 1.112B |
| June 30, 2014 | 752.70M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Johnson & Johnson | 5.363B |
| Merck & Co., Inc. | 5.518B |
| Pfizer Inc. | 4.802B |
| Bristol Myers Squibb Co. | 3.837B |
| Structure Therapeutics, Inc. | -105.57M |